Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Neutra's ebitda for the twelve months ending Oct 31, 2023 was -$191.95K. For fiscal 2023 it was -$218.77K.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | -$218.77K | – |
| FY2022 | Jan 31, 2022 | -$505.80K | – |
| FY2021 | Jan 31, 2021 | -$448.00K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$43.68K | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$58.73K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$51.48K | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$38.06K | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$46.35K | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$62.62K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$71.74K | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$140.94K | – |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | -$155.39K | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$104.98K | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$104.49K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$235.77K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$83.54K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$80.17K | – |
See a number that looks wrong?